CHAPTERS
- 0:02 – 3:26
“Golden Snitch” nickname, and why Novitzky sees himself as an athlete advocate
Joe opens by asking Jeff Novitzky about the “Golden Snitch” nickname and how it’s followed him into the UFC/USADA era. Novitzky jokes about the meme spreading (even to Alexa/Wikipedia), then reframes his actual role as helping athletes succeed under the anti-doping program—not trying to “catch” them.
- 3:26 – 4:15
Donna Marcolini’s day-to-day impact: avoiding “landmines” like whereabouts and supplements
Novitzky explains what Donna does inside the UFC anti-doping ecosystem: proactive help with whereabouts filings, supplement safety, and medication checks. He describes how small compliance mistakes can trigger major problems, and how Donna’s attention to detail reduces those risks.
- 4:15 – 6:33
What USADA is, why UFC outsourced testing, and how program success is measured
Joe pauses to clarify Novitzky’s role and why UFC chose a strict, independent anti-doping program. Novitzky explains USADA’s independence and discusses the challenge of measuring program effectiveness beyond just counting positive tests.
- 6:33 – 12:13
The “testosterone variance” graph: strongest objective evidence UFC anti-doping is working
Novitzky introduces a USADA data analysis showing that steroid users tend to exhibit large swings in urinary testosterone excretion. He walks through a UFC-by-quarter graph showing that variance shrinking over time since USADA began in 2015, presenting it as unusually strong, objective proof of deterrence.
- 12:13 – 22:06
Jon Jones case process: confidentiality, Turinabol detection, and sanction “starting points”
Joe asks where the Jon Jones investigation stands, and Novitzky explains how cases proceed and why they generally don’t comment mid-process. He details Turinabol’s long-term metabolites, why the drug is a strange choice for intentional cheating, and how second-offense sanctions can range widely depending on mitigating/aggravating factors.
- 22:06 – 26:59
Tainted supplements and strict liability: why some athletes still get suspended
The conversation shifts to supplement contamination, using Tim Means as a detailed example of investigative validation. Novitzky explains strict liability, how USADA verifies contamination claims, and why third-party certification is central to reducing risk and potentially reducing sanctions.
- 26:59 – 33:51
Whereabouts compliance and the burden of random testing (plus why top fighters get tested more)
Novitzky and Joe cover whereabouts tools (kiosk/app), common mistakes, and how the system allows limited failures before sanctions. They also address early-morning blood/urine testing burdens and why long-tenured, high-ranked fighters like Holly Holm often get tested most.
- 33:51 – 45:26
Inside the UFC Performance Institute: DEXA scans, recovery tech, and athlete development
Joe and Jeff tour the PI conceptually: DEXA scanning, nutrition planning, rehab tools, sleep pods, and the facility’s ability to change MMA training culture. They discuss staffing, equipment, and how PI resources can spread best practices back to gyms worldwide.
- 45:26 – 59:56
Fighting’s mental game: fight-week psychology, fear management, and different “readiness” styles
Novitzky describes the unique psychological stress of MMA, observing athletes from check-in through fight night. They discuss how fighters manage anxiety differently, an example of someone refusing to enter the arena, and standout mental traits in fighters like Conor McGregor and Justin Gaethje.
- 59:56 – 1:18:11
Brain health and recovery experiments: magnetic therapy, C3 Logic tests, and CTE uncertainty
Joe asks about brain-injury therapies and neurocognitive testing. Novitzky explains experimental magnetic therapy being explored via a San Diego clinic, PI onboarding neurocognitive baselines, and the UFC’s investment in the Cleveland Clinic Fighter Brain Health Study amid uncertainty around living CTE diagnostics.
- 1:18:11 – 1:24:03
Rules, gloves, and officiating: bare-knuckle debate, eye pokes, and inconsistent ‘unified’ rules
Joe argues MMA glove design and hand wrapping may increase damage and doesn’t solve eye pokes, pushing a provocative bare-knuckle stance. Both discuss rule inconsistencies across commissions and advocate more automatic point deductions when fouls cause real damage, regardless of intent.
- 1:24:03 – 1:33:27
Marijuana policy chaos and the Courtney Casey TE-ratio controversy in Texas
Novitzky criticizes inconsistent commission marijuana thresholds that conflict with WADA/USADA standards, including extreme “zero tolerance” policies. He then details Courtney Casey’s case, where Texas publicly announced a ‘positive’ based on a TE ratio without proper IRMS confirmation, causing reputational harm before she was ultimately cleared.
- 1:33:27 – 1:39:32
Rule evolution and athlete advocacy: the ‘Nate Diaz CBD’ change and Nick Diaz whereabouts issues
Novitzky explains how the UFC/USADA program has adjusted rules after seeing unintended consequences. He recounts how Nate Diaz’s post-fight CBD vaping highlighted an unnecessary “four-hour after fight” window, and then explains Nick Diaz’s whereabouts failures and how lifestyle/management can trigger strict-liability sanctions.
- 1:39:32 – 1:54:15
Anti-doping’s cat-and-mouse reality: animal-derived testosterone, biological passports, and Icarus
Joe asks about new doping methods and whether athletes can evade biological passports through consistent microdosing. Novitzky explains why testing alone isn’t enough, how investigations and intelligence matter, and discusses the lessons of Icarus and Russian state-sponsored doping—including conflicts of interest in global governance.
- 1:54:15 – 2:11:02
Weight cutting, IV bans, and morning weigh-ins: reducing risk without creating new dangers
The discussion turns to the UFC’s weight-cutting problem, how the WADA IV ban intersected with rehydration culture, and how UFC sought expert guidance on dehydration limits. Novitzky explains the 8% guideline, California’s initiatives, and why absolute punitive rules can backfire by encouraging more dangerous behavior.
- 2:11:02 – 2:19:11
New blood-collection tech: painless microneedle ‘leeching’ and dried blood spot testing
Novitzky reveals a new USADA collection method using a microneedle device that draws capillary blood painlessly and deposits it on a card for dried-blood-spot testing. They discuss why it’s cheaper, easier to ship, and potentially transformative for expanding anti-doping capabilities beyond major leagues.
